11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with Substance Withdrawal Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnet, U; Borda, T; Scherbaum, N; Specka, M | 1 |
| Budney, AJ; Hughes, JR; Moore, BA; Novy, PL | 1 |
1 trial(s) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Marijuana abstinence effects in marijuana smokers maintained in their home environment.
Topics: Adolescent; Adult; Affective Symptoms; Aggression; Ambulatory Care; Behavior, Addictive; Creatinine; Dronabinol; Feeding and Eating Disorders; Female; Humans; Male; Marijuana Abuse; Middle Aged; Personality Inventory; Psychomotor Agitation; Severity of Illness Index; Sleep Wake Disorders; Substance Abuse Detection; Substance Withdrawal Syndrome; Weight Loss | 2001 |
1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
Topics: Cannabis; Comorbidity; Dronabinol; Female; Humans; Inpatients; Male; Marijuana Abuse; Mental Disorders; Prospective Studies; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 2015 |